 | • レポートコード：MRC2301A150 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、220ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査資料では、2021年に136.1億ドルであった世界の研究用抗体市場規模が、2022年には145.8億ドルになり、その後CAGR 7.32％で拡大して2027年までに208.0億ドルに達すると予想しています。当書は、研究用抗体の世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、機能別（免疫、感染症、神経生物、腫瘍、幹細胞）分析、製品別（モノクローナル抗体、ポリクローナル抗体）分析、ソース別（ヤギ、マウス、ウサギ）分析、技術別（酵素免疫測定法、フローサイトメトリー、免疫蛍光、免疫組織化学、免疫沈降）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成でまとめています。なお、当書に掲載されている企業情報には、Abcam PLC、Agilent Technologies, Inc.、Becton, Dickinson and Company、Bio-Rad Laboratories, Inc.、Biolegend, Inc.、Cell Signaling Technology, Inc.、Danaher Corporation、F. Hoffmann-La Roche AG、GenScript Corporation、Lonza Group、Merck Group、Perkin Elmer, Inc.、QIAGEN, Inc.、Sysmex Corporation、Thermo Fisher Scientific, Inc.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の研究用抗体市場規模：機能別 - 免疫の市場規模 - 感染症の市場規模 - 神経生物の市場規模 - 腫瘍の市場規模 - 幹細胞の市場規模 ・世界の研究用抗体市場規模：製品別 - モノクローナル抗体の市場規模 - ポリクローナル抗体の市場規模 ・世界の研究用抗体市場規模：ソース別 - ヤギの市場規模 - マウスの市場規模 - ウサギの市場規模 ・世界の研究用抗体市場規模：技術別 - 酵素免疫測定法の市場規模 - フローサイトメトリーの市場規模 - 免疫蛍光の市場規模 - 免疫組織化学の市場規模 - 免疫沈降の市場規模 ・世界の研究用抗体市場規模：地域別 - 南北アメリカの研究用抗体市場規模 アメリカの研究用抗体市場規模 カナダの研究用抗体市場規模 ブラジルの研究用抗体市場規模 ... - アジア太平洋の研究用抗体市場規模 日本の研究用抗体市場規模 中国の研究用抗体市場規模 インドの研究用抗体市場規模 韓国の研究用抗体市場規模 台湾の研究用抗体市場規模 ... - ヨーロッパ/中東/アフリカの研究用抗体市場規模 イギリスの研究用抗体市場規模 ドイツの研究用抗体市場規模 フランスの研究用抗体市場規模 ロシアの研究用抗体市場規模 ... - その他地域の研究用抗体市場規模 ・競争状況 ・企業情報 |
The Global Research Antibodies Market size was estimated at USD 13.61 billion in 2021 and expected to reach USD 14.58 billion in 2022, and is projected to grow at a CAGR 7.32% to reach USD 20.80 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Research Antibodies to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Function, the market was studied across Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem Cells.
Based on Operation, the market was studied across Drug Development, Genomics, and Proteomics.
Based on Product, the market was studied across Monoclonal Antibodies and Polyclonal Antibodies.
Based on Source, the market was studied across Goat, Mouse, and Rabbit.
Based on Technology, the market was studied across Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, and Western Blotting.
Based on Type, the market was studied across Primary Antibodies and Secondary Antibodies.
Based on End User, the market was studied across Academic & Research Institutes and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Research Antibodies market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Research Antibodies Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Research Antibodies Market, including Abcam PLC, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biolegend, Inc., Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, GenScript Corporation, Lonza Group, Merck Group, Perkin Elmer, Inc., QIAGEN, Inc., Sysmex Corporation, and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Research Antibodies Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Research Antibodies Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Research Antibodies Market?
4. What is the competitive strategic window for opportunities in the Global Research Antibodies Market?
5. What are the technology trends and regulatory frameworks in the Global Research Antibodies Market?
6. What is the market share of the leading vendors in the Global Research Antibodies Market?
7. What modes and strategic moves are considered suitable for entering the Global Research Antibodies Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing research and development activity and funding
5.1.1.2. Increasing focus in Stem Cell and Neurobiology Research
5.1.1.3. Collaborations between industry and academics
5.1.2. Restraints
5.1.2.1. Time and cost consuming antibody development processes
5.1.3. Opportunities
5.1.3.1. Biomarker Discovery gaining attractive market edge
5.1.3.2. Increasing demand for Protein Therapeutics and Personalized Medicine
5.1.3.3. Growth prospects in emerging markets
5.1.4. Challenges
5.1.4.1. Quality concerns
5.1.4.2. Pricing pressure
5.2. Cumulative Impact of COVID-19
6. Research Antibodies Market, by Function
6.1. Introduction
6.2. Immunology
6.3. Infectious Diseases
6.4. Neurobiology
6.5. Oncology
6.6. Stem Cells
7. Research Antibodies Market, by Operation
7.1. Introduction
7.2. Drug Development
7.3. Genomics
7.4. Proteomics
8. Research Antibodies Market, by Product
8.1. Introduction
8.2. Monoclonal Antibodies
8.3. Polyclonal Antibodies
9. Research Antibodies Market, by Source
9.1. Introduction
9.2. Goat
9.3. Mouse
9.4. Rabbit
10. Research Antibodies Market, by Technology
10.1. Introduction
10.2. Enzyme-linked Immunosorbent Assay
10.3. Flow Cytometry
10.4. Immunofluorescence
10.5. Immunohistochemistry
10.6. Immunoprecipitation
10.7. Western Blotting
11. Research Antibodies Market, by Type
11.1. Introduction
11.2. Primary Antibodies
11.3. Secondary Antibodies
12. Research Antibodies Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Pharmaceutical & Biotechnology Companies
13. Americas Research Antibodies Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Research Antibodies Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Research Antibodies Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Abcam PLC
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Agilent Technologies, Inc.
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. Becton, Dickinson and Company
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Bio-Rad Laboratories, Inc.
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. Biolegend, Inc.
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Cell Signaling Technology, Inc.
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Danaher Corporation
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. F. Hoffmann-La Roche AG
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. GenScript Corporation
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. Lonza Group
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. Merck Group
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. Perkin Elmer, Inc.
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. QIAGEN, Inc.
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. Sysmex Corporation
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Thermo Fisher Scientific, Inc.
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing